2004
DOI: 10.1097/01.mjt.0000101826.94820.6b
|View full text |Cite
|
Sign up to set email alerts
|

Emerging Technologies in Transdermal Therapeutics

Abstract: Until very recently, the only drugs that could permeate transdermally were those possessing a very narrow and specific combination of physicochemical properties. However, rapid advances in bioengineering have led to the emergence of various new "active" enhancement technologies designed to transiently circumvent the barrier function of the stratum corneum. These novel systems, using iontophoresis, sonophoresis, electroporation, or microneedle arrays, will greatly expand the range of drugs that can be delivered… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(8 citation statements)
references
References 21 publications
0
8
0
Order By: Relevance
“…This is expected to be true only if transport across skin is occurring through the intercellular lipid domain of SC and there is no effect of the solvent used on the barrier properties of SC. In general, parameters such as molecular weight below 500 Da, logP around 2 and low melting point are often evoked as favorable physicochemical characteristics of a drug intended for transdermal delivery (40)(41)(42).…”
Section: Parameters In Classical Transdermal Transportmentioning
confidence: 99%
“…This is expected to be true only if transport across skin is occurring through the intercellular lipid domain of SC and there is no effect of the solvent used on the barrier properties of SC. In general, parameters such as molecular weight below 500 Da, logP around 2 and low melting point are often evoked as favorable physicochemical characteristics of a drug intended for transdermal delivery (40)(41)(42).…”
Section: Parameters In Classical Transdermal Transportmentioning
confidence: 99%
“…Moreover, optimistic expectations of dermal and transdermal drug delivery (TDD) were often thwarted by many pitfalls inherent to this science. Most notably, the outermost nonviable layer of the epidermis, the stratum corneum, has proved particularly resistant to TDD due to its lipid bilayer architectural design [13,14] . As a result, this places a major limitation on the physicochemical profile displayed by compounds which qualify as candidates for TDD.…”
Section: Frum /Viljoenmentioning
confidence: 99%
“…It is proposed that KT stimulates Aβ mechanoreceptors with slow threshold and increase afferent signals to high levels of central nervous system and finally blocks the pain receptors (Aδ and C fibers) result in nerve depolarization and inhibition of pain-spasm circle [30]. Another theory is that KT increases circulation and improves pain intensity [31].…”
Section: Discussionmentioning
confidence: 99%